OliX Pharmaceuticals to Participate in BIO Partnering at JPM and Biotech Showcase 2022 Conferences
SUWON, Republic of Korea., Jan. 03, 2022 (GLOBE NEWSWIRE) -- OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi...
Month: January 2022
Myovant Sciences to Present at the 40th Annual J.P. Morgan Healthcare Conference
BASEL, Switzerland, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women...
Todos Medical to Present at January 5, 2022 Emerging Growth Conference
NEW YORK, NY and TEL AVIV, Israel, Jan. 03, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:...
The Greenrose Holding Company Closes Asset Purchase of True Harvest, LLC
- True Harvest Expands Greenrose’s Footprint into Arizona and Establishes Strong Cultivation Presence in the Southwest - - Greenrose Provides...
Spero Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for Tebipenem HBr for the Treatment of Complicated Urinary Tract Infections including Pyelonephritis
The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of June 27, 2022CAMBRIDGE, Mass., Jan. 03,...
Allarity Therapeutics and Oncoheroes Biosciences Sign Agreements to Advance Pediatric Cancer Development of Dovitinib and Stenoparib
Press release Oncoheroes will fund and advance the clinical development of both dovitinib and stenoparib in pediatric...
Ortho Clinical Diagnostics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
RARITAN, N.J., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics Holdings plc (Nasdaq: OCDX), one of the world’s largest...
U.S. Food and Drug Administration Approves Immix Biopharma Rare Pediatric Disease Designation for IMX-110 as a Treatment for Life-Threatening Pediatric Cancer in Children
Rare Pediatric Disease Designation (“RPDD”) qualifies Immix Biopharma to receive fast track review, and a priority review voucher (“PRV”) at...
InnerScope Hearing Technologies (OTC: INND) CEO to Present at The Emerging Growth Conference on Jan. 5, 2022
InnerScope invites individual and institutional investors as well as advisors and analysts to attend its real-time, interactive presentation at the...
Alignment Healthcare To Participate in Upcoming J.P. Morgan Healthcare Conference
ORANGE, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (“Alignment Healthcare” or the “Company”) (Nasdaq: ALHC), a tech-enabled...
Propella Therapeutics Invited to Present at 2022 ASCO Genitourinary (GU) Cancers Symposium and to Participate in the LifeSci Partners 11th Annual Corporate Access Event
ASCO GU Presentation Highlight Nonclinical Data of Next-Generation Androgen Biosynthesis Inhibitor, PRL-02, for Treatment of Advanced Prostate Cancer Company Senior...
Augmedix to Participate at the 11th Annual LifeSci Partners Corporate Access Event
SAN FRANCISCO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX), a leading provider of virtual medical documentation and...
Xtant Medical Appoints Scott Neils Interim Chief Financial Officer
BELGRADE, Mont., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company...
Intra-Cellular Therapies to Present at the 40th Annual J.P. Morgan Healthcare Conference
NEW YORK, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development...
Cabaletta Bio to Present at the H.C. Wainwright BioConnect Conference
PHILADELPHIA, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery...
Enlivex to Detail the Application of its Innovative Macrophage Reprogramming Cell Therapy to Unmet Needs in Oncology at the 11th Annual LifeSci Partners Corporate Access Event
** Management to participate in a panel discussion: “Innovative Approaches to Cell Therapy for Oncology,” which is taking place on...
Prometheus Biosciences and Dr. Falk Pharma Advance PR600 and Trigger Final Preclinical Milestone Payment
Investigational New Drug Application for PR600 expected in 3Q 2022SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc....
ORYZON to Hold Multiple Corporate Activities in January
40th Annual J.P. Morgan Healthcare ConferenceBiotech Showcase 202211th Annual LifeSci Partners Corporate Access Event 2022H.C. Wainwright Bioconnect ConferenceBioMed Event 2022...
VYNE Therapeutics to Participate at the LifeSci Partners 11th Annual Corporate Access Event
BRIDGEWATER, N.J., Jan. 03, 2022 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that...
InnovAge Announces the Resignation of CEO Maureen Hewitt and the Appointment of Patrick Blair as President and CEO
DENVER, Jan. 03, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of InnovAge Holding Corp. (the “Company” or “InnovAge”) (Nasdaq:...
